Jeff Baxter
Vorstandsvorsitzender bei VBI VACCINES INC.
Vermögen: 12 144 $ am 30.04.2024
Aktive Positionen von Jeff Baxter
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VBI VACCINES INC. | Direktor/Vorstandsmitglied | 01.05.2016 | - |
| Vorstandsvorsitzender | 01.05.2016 | - | |
| Präsident | 01.05.2016 | - | |
Variation Biotechnologies (US), Inc.
 Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | 22.09.2009 | - |
| Vorstandsvorsitzender | 22.09.2009 | - | |
| Präsident | 22.09.2009 | - | |
VBI Vaccines (Delaware), Inc.
 VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Direktor/Vorstandsmitglied | 01.07.2014 | - |
| Vorstandsvorsitzender | 01.07.2014 | - | |
| Präsident | 01.07.2014 | - |
Karriereverlauf von Jeff Baxter
Ehemalige bekannte Positionen von Jeff Baxter
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CHROMADEX CORPORATION | Direktor/Vorstandsmitglied | 16.04.2015 | 04.04.2022 |
| Independent Dir/Board Member | 16.04.2015 | 04.04.2022 | |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Chief Investment Officer | - | 28.02.2009 |
| Private Equity Investor | - | 28.02.2009 | |
| GSK PLC | Corporate Officer/Principal | 01.01.2002 | 01.07.2006 |
| UNILEVER PLC | Corporate Officer/Principal | - | - |
| BRITISH AMERICAN TOBACCO P.L.C. | Corporate Officer/Principal | - | - |
Ausbildung von Jeff Baxter
| University of West London | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Vereinigtes Königreich | 5 |
Operativ
| Director/Board Member | 4 |
| Chief Executive Officer | 3 |
| President | 3 |
Sektoral
| Health Technology | 6 |
| Consumer Non-Durables | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| BRITISH AMERICAN TOBACCO P.L.C. | Consumer Non-Durables |
| UNILEVER PLC | Consumer Non-Durables |
| GSK PLC | Health Technology |
| CHROMADEX CORPORATION | Health Technology |
| VBI VACCINES INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
The Column Group LLC
The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Finance |
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Health Technology |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Health Technology |
- Börse
- Insiders
- Jeff Baxter
- Erfahrung
